【24h】

The influence of fumaric anhydride on bioadhesive polymer compositions

机译:富马酸酐对生物粘附性聚合物组成的影响

获取原文
获取原文并翻译 | 示例

摘要

Bioadhesive polymers are useful as drug delivery systems designed to adhere to the gastrointestinal lumen. The interaction between polymer ad mucosal tissue influences residence time of the polymeric device and greatly affects the bioavailability of encapsulated drug. Poly(fumaric-co-sebacic anhydride) [P(FA:SA)] demonstrated impressive results in a variety of in vitro and in vivo experiments designed to test bioadhesion of microspheres. Among different molar ratios of P(FA:SA), adhesive measurements increased with increasing fumaric acid (FA) content. Using a modified microbalance technique, P(FA;SA) 10:90 yielded a tensile work measurement of 82.99+-12.76 nJ (mean+-SEM) while that for P(FA:SA)70:30 was 453.23+-47.73 nJ. A low molecular weight substance, fumaric anhydride prepolymer (FAPP), the oligomer form of fumaric acid, was incorporated into the microspheres and greatly increased the bioadhesive properties of P(FA:SA) as well as those of the relatively non-bioadhesive polymer poly(caprolactone) (PCL). Tensile work of P(FA:SA)20:80 was 32.95+-5.42 nJ, and P(FA:SA)20:80 with 25percent FAPP yielded a tensile work measurement of 556.28+-113.12 nJ. Adhesion testing with PCL yielded a tensile work measurement of 7.93+-1.84 nJ, while that for PCL with 25percent FAPP was 1629.54+-307.55 nJ. The effect of FA on drug delivery was evaluated in vitro using the P(FA:SA):FAPP blend with the everted intestinal sac technique. A low molecular weight drug (sodium salicylate) encapsulated in P(FA:SA)20:80 passed through the everted intestinal lumen to the interior of the sac to yield a concentration of 11.17+-0.93 mg/dL, and drug encapsulated in P(FA:SA)20:80 with 10percent FAPP yielded a concentration of 16.25+-1.68 mg/dL (P<=0.05). Unencapsulated drug passed through the intestinal lumen to yield a concentration of 8.09+-0.36 mg/dL. These experiments demonstrate that fumaric anhydride could be a very important component in bioadhesive polymer systems.
机译:生物粘附性聚合物可用作设计成粘附至胃肠腔的药物递送系统。聚合物和粘膜组织之间的相互作用影响聚合物装置的停留时间,并极大地影响封装药物的生物利用度。聚(富马酸-共-癸二酸酐)[P(FA:SA)]在旨在测试微球生物粘附力的各种体外和体内实验中均显示出令人印象深刻的结果。在不同摩尔比的P(FA:SA)中,胶粘剂的测量值随着富马酸(FA)含量的增加而增加。使用改进的微量天平技术,P(FA; SA)10:90得出的拉伸功测量值为82.99 + -12.76 nJ(平均值±SEM),而P(FA:SA)70:30的拉伸功测量值为453.23 + -47.73 nJ。低分子量物质富马酸酐预聚物(FAPP)(富马酸的低聚物形式)被掺入微球中,大大提高了P(FA:SA)以及相对非生物粘附性聚合物poly的生物粘附性(己内酯)(PCL)。 P(FA:SA)20:80的拉伸功为32.95 + -5.42 nJ,具有25%FAPP的P(FA:SA)20:80的拉伸功测量值为556.28 + -113.12 nJ。 PCL的粘合力测试得出的拉伸功测量值为7.93±-1.84 nJ,而FAPP为25%的PCL的拉伸功测量值为1629.54 + -307.55 nJ。使用P(FA:SA):FAPP共混物和外翻肠囊技术在体外评估FA对药物递送的影响。封装在P(FA:SA)20:80中的低分子量药物(水杨酸钠)通过外翻的肠腔到达囊内部,浓度为11.17 + -0.93 mg / dL,并且封装在P中具有10%FAPP的(FA:SA)20:80产生的浓度为16.25±1.68 mg / dL(P <= 0.05)未封装的药物通过肠腔,浓度为8.09 + -0.36 mg / dL。这些实验表明,富马酸酐可能是生物粘附性聚合物系统中非常重要的组分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号